363 related articles for article (PubMed ID: 12177100)
1. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
[TBL] [Abstract][Full Text] [Related]
4. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Ignatiadis M; Perraki M; Apostolaki S; Politaki E; Xenidis N; Kafousi M; Stathopoulos E; Lianidou E; Sotiriou C; Georgoulias V; Mavroudis D
Clin Breast Cancer; 2007 Dec; 7(11):883-9. PubMed ID: 18269779
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.
Tryfonidis K; Kafousi M; Perraki M; Apostolaki S; Agelaki S; Georgoulias V; Stathopoulos E; Mavroudis D
Clin Breast Cancer; 2014 Dec; 14(6):442-50. PubMed ID: 24958324
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Xenidis N; Perraki M; Kafousi M; Apostolaki S; Bolonaki I; Stathopoulou A; Kalbakis K; Androulakis N; Kouroussis C; Pallis T; Christophylakis C; Argyraki K; Lianidou ES; Stathopoulos S; Georgoulias V; Mavroudis D
J Clin Oncol; 2006 Aug; 24(23):3756-62. PubMed ID: 16769987
[TBL] [Abstract][Full Text] [Related]
8. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
[TBL] [Abstract][Full Text] [Related]
9. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
10. Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Mavroudis D; Kouroussis C; Mavroudi C; Perraki M; Sivridis E; Georgoulias V
Int J Cancer; 2004 Feb; 108(4):620-7. PubMed ID: 14696130
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Wei YH
Int J Cancer; 2002 Feb; 97(4):548-53. PubMed ID: 11802221
[TBL] [Abstract][Full Text] [Related]
12. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
13. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
[TBL] [Abstract][Full Text] [Related]
17. The detection of circulating breast cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
Bae JW; Choi KH; Kim HG; Park SH
J Korean Med Sci; 2000 Apr; 15(2):194-8. PubMed ID: 10803697
[TBL] [Abstract][Full Text] [Related]
18. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
[TBL] [Abstract][Full Text] [Related]
19. A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer.
Stathopoulou A; Ntoulia M; Perraki M; Apostolaki S; Mavroudis D; Malamos N; Georgoulias V; Lianidou ES
Int J Cancer; 2006 Oct; 119(7):1654-9. PubMed ID: 16708381
[TBL] [Abstract][Full Text] [Related]
20. Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Stathopoulos EN; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
Ann Oncol; 2005 Feb; 16(2):240-6. PubMed ID: 15668277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
